In our study, we tested the presence of HPV infection and RAD51 expression in the oral cavity and oropharyngeal cancer as predictive and prognostic markers for 2-year, 5-year, and overall survival in patients who were not eligible for surgery or chemoradiotherapy and, thus, in whom curative radiotherapy remained the only treatment option. This evidence concerns the gene RAD51 and oropharynx cancer.